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INTRODUCTION
Right heart thrombi in transit represent deep venous thrombi that have mobilized and become lodged in the right heart en route to the pulmonary arteries, with the potential to migrate and lead to additional embolic complications. Due to their increased risk for mortality, right heart thrombi in transit represent a severe form of venous thromboembolism. In addition, in patients with patent foramen ovale (PFO) or atrial septal defect (ASD), right heart thrombi in transit can lead to systemic thromboembolism. Once diagnosed, right heart thrombi in transit require consideration of emergent treatment such as thrombolytics, surgical thromboembolectomy, or catheter-based intervention, due to the potential of the clot to fragment or migrate leading to further vascular obstruction and hemodynamic compromise.
CASE REPORT
A 32-year-old man with no significant medical history presented with left-sided pleuritic chest pain and dyspnea on exertion for approximately 12 days. His symptoms began shortly after a 6-h flight. The patient also experienced myalgias, vomiting, and fatigue and had spent several days in bed with what he believed was a viral illness. Vital signs on arrival to the emergency department were as follows: heart rate: 113 beats/min (regular); blood pressure: 101/85 mm Hg; respiratory rate: 25 breaths/ min; oxygen saturation, 93% on 4 L oxygen via nasal cannula. Physical examination revealed an ill-appearing man with marked cyanosis and mottling of the lower extremities. Jugular venous pressure was elevated to 14 cm and cardiac examination revealed an increased intensity of the pulmonic component of the second heart sound. The remainder of the physical examination was otherwise normal.
Complete blood count was remarkable for a leukocytosis of 14 and a hematocrit of 49.6%. Chemistry findings were normal, with the exception of the creatinine (1.67 mg/dL). Cardiac troponin (cTnI) was mildly elevated at 0.153 mg/mL. Electrocardiogram was remarkable for right ventricular strain.
Point of care cardiac ultrasound was immediately performed and revealed a moderately dilated right ventricle with reduced systolic function. In addition, there was a large, mobile, snake-like echodensity within the right atrium, extending into the right ventricle, where it appeared to be moving back and forth ( Figure 1) 20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61   62  63  64  65  66  67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129 density in the right heart and a saddle pulmonary embolism (PE) with extension into the right and left main pulmonary artery, as well as interlobar, lobar, and segmental arteries were visualized ( Figure 2 ). Recombinant tissue plasminogen activator (t-PA) 10 mg via intravenous bolus was immediately administered, followed by 90 mg infusion over 2 h, in order to treat the patient's right heart thrombus in transit and severe PE. Shortly after administration of t-PA, the patient's oxygen saturation improved to 99% on room air and his extremities became warm and well-perfused. Upon arrival to the intensive care unit, the patient developed an episode of epistaxis that required nasal packing. Six hours after t-PA administration, a formal transthoracic echocardiogram showed complete resolution of the right heart thrombus in transit (Figure 3) .
The patient continued to do well clinically and was placed on anticoagulation with heparin. Repeat formal echocardiography showed marked improvement of right ventricular dilatation and right ventricular systolic function, with near normalization of the pulmonary artery pressures. Lower-extremity ultrasonography demonstrated an extensive left femoral vein thrombus extending into the popliteal vein. Placement of an inferior vena cava filter was considered, but ultimately one was not placed because the patient was able to tolerate anticoagulation. The patient remained hemodynamically stable and was eventually bridged from heparin to warfarin and discharged from the hospital once his international normalized ratio was therapeutic.
DISCUSSION
Right heart thrombi in transit are often found in the setting of severe bilateral PEs (1,2). Dyspnea, chest pain, and syncope are the most common presenting symptoms. Patients with right heart thrombi in transit often have higher heart rates, lower blood pressures, and exhibit more right ventricular dysfunction compared with patients who present with PE without right heart thrombi in transit (1) . Patients can also present in cardiogenic shock. The reported incidence in patients with PE is between 3.6% and 18% (1À3).
The diagnosis of right heart thrombi in transit is usually made by echocardiography or CT pulmonary angiography. Point of care ultrasound, as in our case, can lead to a more prompt diagnosis. On these imaging modalities, a right heart thrombus in transit has been described as a highly mobile, coiled, or serpiginous mass, usually in the right atrium with prolapse into the ventricle (3, 4) .
A right heart thrombus in transit is an ominous manifestation of venous thromboembolism that requires a more aggressive and emergent management approach, as nearly all deaths occur within the first 24 h (5). However, the optimal treatment remains somewhat controversial. Thrombolytics and surgical embolectomy are the most described and well-validated treatment modalities. Successful treatment with anticoagulation alone has been 130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197   198  199  200  201  202  203  204  205  206  207  208  209  210  211  212  213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265 documented, but there is substantial evidence that this treatment is inadequate and, in some studies, equivocal Q2 to no treatment (1, 4) . In addition, anticoagulation may have a slow onset of action and lead to fragmentation and embolization of a right heart thrombus in transit.
Although the presence of right heart thrombi in transit is associated with increased mortality, little is known about optimal management of this difficult clinical situation. In addition to anticoagulation, there are several other therapeutic options that should be considered for the management of right heart thrombi in transit. These includes systemic thrombolysis, surgical embolectomy, and catheter-based treatments. Thrombolytics have been shown to dissolve right heart thrombi in transit and lead to improvements in right heart strain, pulmonary vascular resistance, and pulmonary hemodynamics. Urokinase, streptokinase, or t-PA are typically used; the dose of t-PA that is typically used for massive PE is 100 mg over 2 h (6). Treatment monitoring can be done effectively by serial echocardiography. Most right heart thrombi in transit resolve within 2 h of administration of thrombolytics, but occasionally have been known to take up to 12 or even 24 h to resolve (7) . The major risk associated with thrombolytic therapy is significant bleeding and it should therefore be avoided in patients with contraindications, including recent surgery or stroke.
Surgical embolectomy is considered a classic treatment for right heart thrombi in transit and may be the treatment of choice when the need for a repair of a PFO simultaneously exists to prevent paradoxical emboli, or when thrombolytic therapy is contraindicated (5). Surgical embolectomy allows for rapid removal of thrombi from the right heart and both of the pulmonary arteries. This procedure has the potential advantage of repairing a PFO or a septal defect, if present.
There have been case reports documenting the use of percutaneous catheterization to retrieve right heart thrombi in transit (8, 9) . During this procedure, a sheath is introduced into the femoral vein and into the right heart. From there, the right heart thrombus in transit is attached to the sheath using the negative pressure from a syringe or a basket device is used to capture the thrombus and move it into the inferior vena cava (IVC) and an IVC filter is placed, in theory preventing the thrombus from re-entering the right heart. Transesophageal echocardiography may be used to provide visualization during the procedure. The risks of percutaneous retrieval include further embolization of the right heart thrombus or perforation of vital cardiovascular structures. Although this strategy has been shown to be technically feasible, it is not meant to be an alternative to thrombolytics or surgery and its purpose is to serve as a salvage treatment for those with contraindications to both of these treatments.
The diagnosis of right heart thrombi in transit carries poor prognostic significance. In-hospital mortality has been reported to be as high as 45% (10) . Treatment with surgery or thrombolytics has been shown to significantly reduce mortality when compared to treatment with anticoagulation alone. There are no randomized controlled trials comparing surgery to thrombolytics but, in a metaanalysis, there was improved survival rate in patients treated with thrombolytics (4). Patients with right heart thrombi in transit who survive hospitalization generally have a favorable prognosis after discharge.
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